Bioregulators

Limitless Cartilage Bioregulator (Sigumir)

$59.99

Description

Amount Per Capsule
Sigumir® bioregulator complex A-4 (bovine cartilage amino acid) – 10mg*

*Daily Value not established

Other ingredients

Microcrystalline Cellulose, Gelatin and Calcium Stearate

The protein complex in this product is derived from organ meats sourced from EU-reared beef cattle.

Sigumir Cartilage Peptide Bioregulator

Sigumir A-4 Cartilage Peptide Bioregulator is a natural peptide complex derived from the cartilage and bone tissues of young animals. It is used in research to study its effects on the musculoskeletal system, particularly in supporting joint and bone health. Sigumir works by normalizing the metabolism and functions of cartilage and bone tissues, promoting protein synthesis, and addressing peptide deficiencies.

Research applications include investigating its potential to aid in the recovery of joint and spine functions after diseases, reduce inflammation, and improve mobility. It is also studied for its role in managing conditions like arthritis, osteochondrosis, osteoporosis, and rheumatism. Sigumir’s bioactive peptides are known for their ability to rejuvenate joint tissues and improve overall joint flexibility and comfort.

Potential Research Applications

Sigumir’s diverse applications in joint and bone health make it a promising candidate for further research in several therapeutic areas and a subject of interest for various medical conditions.

Joint Health and Mobility: Sigumir supports the regeneration of joint tissues, which can help alleviate discomfort and improve mobility. This makes it a potential treatment for conditions like arthritis, osteoarthritis, and general joint stiffness.

Bone Health: The peptide complex in Sigumir aids in maintaining bone density and health. This could be potentially beneficial for elderly individuals and post-menopausal women who are at higher risk of osteoporosis and fractures.

Musculoskeletal Disorders: Sigumir has shown effectiveness in treating degenerative-dystrophic disorders of the joints and spine. It offers potential to be studied as part of a comprehensive treatment plan for conditions like osteochondrosis and rheumatism.

Post-Surgical Recovery: The regenerative properties of Sigumir peptides could aid in the recovery of musculoskeletal functions after surgeries or injuries. This may include improving the healing process and reducing recovery time.

Age-Related Degeneration: As a geroprotective agent, Sigumir may help slow down age-related degeneration of cartilage and bone tissues, contributing to overall musculoskeletal health in aging populations.

Therapeutic Areas of Interest

  • Osteoarthritis
  • Osteoporosis
  • Osteochondrosis
  • Temporomandibular joint diseases

Studies of Interest

  1. Myakisheva SN, Linkova NS, Kozhevnikova EO, Ryzhak GA. [Chondrocytes secretory phenotype associated with aging: role in the pathogenesis of osteoarthritis and prospects for peptide bioregulation.]. Adv Gerontol. 2023;36(3):313-323. Russian. PMID: 37782637.

Similar Products

Scroll to Top